Improving adherence to chronic disease medication regimens among patients with recently diagnosed cancer: a pilot study
NCT ID NCT07811258
First seen Sep 10, 2026 · Last updated Sep 10, 2026
Summary
This pilot study evaluates a pharmacist-led medication adherence intervention and Medisafe mobile application among patients with newly diagnosed cancer and multimorbidity. Thirty participants will be randomized to intervention or usual care to assess feasibility, acceptability, usability, and preliminary efficacy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * diagnosed with breast, colorectal, lung or prostate cancer in the previous 12 months * had no prior diagnosis of cancer * are currently undergoing chemotherapy or radiation and/or underwent surgery in the prior 3 months * had \>2 chronic conditions for \>1 year prior to cancer diagnosis * are prescribed \>1 non-cancer medication(s) Exclusion Criteria: * cannot read and communicate in English * do not have a smartphone
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cancer are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Effects of a brief Mindfulness-Based chatbot intervention (Mindbot) on mindfulness level and stress among cancer patients: a randomized controlled trial
- Évaluation de la détresse post-traumatique relative au cancer dans l'année suivant le diagnostic chez les patients et les aidants et identification de leurs attentes envers un accompagnement personnalisé
- Development and pilot implementation of a novel remote patient monitoring program for cancer patients initiating cancer-directed therapy: the SHIELD (Smart health integration for early life-saving detection)
- The promoting resilience in stress Management-Social needs (PRISM-SN) intervention for adolescents and young adults with cancer: a randomized controlled trial
- An equity focused intervention to improve utilization of guideline concordant extended venous thromboembolism prophylaxis after major cancer surgery
- The effect of gamified sleep hygiene education on sleep quality and fatigue levels in chemotherapy patients